USANA Health Sciences Reports Second Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
USANA Health Sciences (USNA) Tops Q2 EPS by 24c, Revenues Beat; Raises FY20 EPS/Revenue Outlook
July 21, 2020 4:19 PM EDTUSANA Health Sciences (NYSE: USNA) reported Q2 EPS of $1.32, $0.24 better than the analyst estimate of $1.08. Revenue for the quarter came in at $259 million versus the consensus estimate of $256.33 million.
Key Financial & Operating Highlights
Continued strong demand and successful promotions combined to generate $259.0 million in net sales and $1.32 in diluted EPS during the quarterActive customers increased 7.9% vs. the prior-year quarterCompany continued to successfully execute a virtual sales and operating strategy to deliver resultsCompany raises full-year 2020 Net Sales and EPS outlookStrong consumer demand for our high-quality, health products and... More
